Enzyme Or Microbial Cell Is Entrapped Within The Carrier (e.g., Gel, Hollow Fibre) Patents (Class 435/182)
-
Patent number: 8771720Abstract: Polyhydroxyalkanoates (PHAs) from which pyrogen has been removed are provided. PHAs which have been chemically modified to enhance physical and/or chemical properties, for targeting or to modify biodegradability or clearance by the reticuloendothelial system (RES), are described. Methods for depyrogenating PHA polymers prepared by bacterial fermentation processes are also provided, wherein pyrogens are removed from the polymers without adversely impacting the polymers' inherent chemical structures and physical properties. PHAs with advantageous processing characteristics, including low melting points and/or solubility in non-toxic solvents, are also described. The PHAs are suitable for use in in vivo applications such as in tissue coatings, stents, sutures, tubing, bone, other prostheses, bone or tissue cements, tissue regeneration devices, wound dressings, drug delivery, and for diagnostic and prophylactic uses.Type: GrantFiled: July 10, 2012Date of Patent: July 8, 2014Assignee: Metabolix, Inc.Inventors: Simon F. Williams, David P. Martin, Tillman Gerngross, Daniel M. Horowitz
-
Publication number: 20140186908Abstract: Disclosed are processing systems and processes for carrying out enzymatic batchwise or continuous process for the production of fatty acid alkyl esters for use in the biofuels, food and detergent industries.Type: ApplicationFiled: December 30, 2013Publication date: July 3, 2014Applicant: Trans Biodiesel Ltd.Inventors: Sobhi BASHEER, Usama MOHSEN
-
Publication number: 20140178964Abstract: The invention provides polymer scaffolds for cell-based tissue engineering.Type: ApplicationFiled: April 12, 2012Publication date: June 26, 2014Applicant: President and Fellows of Harvard CollegeInventors: David J. Mooney, Jaeyun Kim, Sidi A. Bencherif, Weiwei A. Li
-
Patent number: 8759056Abstract: A process for the production of granules or pellets containing filamentous fungi is described comprising the steps of selecting and growing filamentous fungi in a suitable culture medium for a predetermined amount of time, adding a gelling agent and at least one carrier to said culture medium, so as to obtain a mixture, subjecting said mixture to gelling through contact, drop by drop, with a solution containing a calcium salt thus obtaining gelled pellets or granules containing said filamentous fungi and drying said gelled pellets or granules to a moisture content of 13-18%.Type: GrantFiled: February 8, 2005Date of Patent: June 24, 2014Assignee: Urea Casale SAInventor: Elisabeth Panchaud-Mirabel
-
Patent number: 8753856Abstract: The present invention provides a stable and viable biocatalyst with high activity and operational stability and method of immobilization thereof. The immobilization process is based on the principle of entrapment of partially purified enzyme precipitate which is simultaneously aggregated by cross linking agent like glutaraldehyde and further entrapped in a combination of natural polymer like gelatin and synthetic polymer like polyvinyl alcohol with effective gelation under mild conditions of temperature and pH, resulting in a stable biocatalyst. The enzymes immobilized by the above process include Penicillin acylase from rE. coli RE III (pKA18), Novel Penicillin acylase from Achromobacter sp (CCM4834) expressed in rE. coli BL21 (pK1P1) CCM 7394 and rE. coli RE III (pKX1P1).Type: GrantFiled: November 14, 2008Date of Patent: June 17, 2014Assignee: Fermenta Biotech Ltd.Inventors: Anupama Datla, Rajasekar Vyasarayani Williams, Trupti Krishnakant Ashar, Pavel Kyslik, Stanislav Becka
-
Publication number: 20140147885Abstract: Semi-permeable particle can be used to facilitate chemical reactions such as catalytic reactions. The semi-permeable particles are permeable to molecules having a molar mass of 1000 Daltons or less and have a mode particle size of at least 1 ?m. The semi-permeable particles have multiple discrete cavities containing an aqueous solution or suspension of an organic catalytic material. The semi-permeable particles are also impermeable to the organic catalytic materials so they are retained within the multiple discrete cavities, and the semi-permeable particles can be reused multiple times for the same or different chemical reaction.Type: ApplicationFiled: November 28, 2012Publication date: May 29, 2014Inventors: Mark R. Mis, Mridula Nair, Douglas R. Robello
-
Patent number: 8735117Abstract: In on aspect, the invention includes a microcarrier bead having a porous three-dimensional core having (a) a polymeric porous three-dimensional body having porosity of about 15 to about 90% such that at least 99% of pores are interconnected and have diameters of at most 200 microns, (b) an outer protective layer and optionally (c) a filler. In another aspect, the invention includes a method of making an artificial scaffold wherein a scaffolding material is extruded into a coolant and thereby creating a porous material having a porosity of between 15-90% such that at least 99% of pores are interconnected and have diameters of at most 200 microns.Type: GrantFiled: September 8, 2010Date of Patent: May 27, 2014Assignee: Drexel UniversityInventors: Andrew Darling, Lauren Shor, Wei Sun, Selcuk Guceri
-
Patent number: 8735140Abstract: The present invention relates to compositions and uses of a novel Dunaliella salina HT04 microorganism. In addition, the present invention relates to novel methods for culturing harvesting, preservation, storage, and production of algae seedstock and uses thereof.Type: GrantFiled: January 30, 2012Date of Patent: May 27, 2014Assignee: Kuehnle AgroSystems, Inc.Inventor: Adelheid R. Kuehnle
-
Publication number: 20140134701Abstract: The present invention discloses a bacteriorhodopsin-containing bioactive gel and a method for fabricating the same, wherein a thickening polymeric compound is suspended in water to form a base gel having appropriate glutinosity and suitable for skin, and wherein a bacteriorhodopsin-containing culture fluid, which is obtained via culturing halobacteria in a spent culture fluid, is integrated with the glutinous base gel to form the bacteriorhodopsin-containing bioactive gel. The bioactive gel of the present invention is abundant of vitamins, minerals, amino acids, etc. and thus very useful in beauty treatment and dermatological treatment. The present invention is also expected to have high commercial potential in many other fields.Type: ApplicationFiled: December 27, 2012Publication date: May 15, 2014Applicant: B.R.L. LABORATORY INC.Inventor: Alexander BRASLAVSKIY
-
Patent number: 8715639Abstract: The present invention relates to the field of bacteriology. In particular, the invention relates to compositions of probiotic microbes and methods for making and using such compositions, e.g. in the treatment and prevention of catheter associated urinary tract infections.Type: GrantFiled: September 7, 2007Date of Patent: May 6, 2014Assignee: Conjugon, Inc.Inventors: Hideki Suzuki, Salvatore Braico
-
Patent number: 8715983Abstract: The present invention is directed to a hydrogel network comprised of a physically cross-linked polymer and a chemically cross-linked polymer or physically entangled copolymer containing living cells, such as chondrocytes, encapsulated therein. In a preferred aspect, the physically cross-linked polymer is selected from the group consisting of thermally gelling polysaccharides and proteins, such as agarose or gelatin, and the chemically cross-linked or physically entangled polymer is synthesized from a water-soluble vinyl monomer, either as a homopolymer or copolymer, such as polyethylene glycol diacrylate (“PEG-DA”) and 2-hydroxyethyl methacrylate (“HEMA”).Type: GrantFiled: September 5, 2012Date of Patent: May 6, 2014Assignee: University of KansasInventors: Michael Detamore, Stevin H. Gehrke
-
Patent number: 8703458Abstract: A polymer matrix that may coated on an electrode is created by co-crosslinking (1) an adduct of a polyaniline formed by templated oxidative polymerization on a polymer acid; (2) a water-soluble crosslinker; and (3) a redox enzyme. The polymer matrix may be hydrated, and the absorbed water may make it permeable to, for example, glucose. The polyaniline may be polyaniline itself or a substituted polyaniline; the water-soluble crosslinker may be poly(ethylene glycol) diglycidyl ether, and the redox enzyme may be glucose oxidase. The polymer matrix may be produced by co-crosslinking (1) an adduct of an electrically conductive polymer and a polymer acid; (2) a water-soluble crosslinker; and (3) a redox enzyme in a single step at an about neutral pH, curing by drying. After hydration, the crosslinked polymer matrix may form a 3-dimensional glucose-permeable bioelectrocatalyst, catalyzing the electrooxidation of glucose.Type: GrantFiled: January 31, 2013Date of Patent: April 22, 2014Assignee: Abbott Diabetes Care Inc.Inventors: Adam Heller, Benjamin J. Feldman, Nicolas Mano, Yueh-Lin Loo
-
Patent number: 8697111Abstract: An osteochondral plug includes a first scaffold and a second scaffold. The first scaffold may be a solid scaffold containing one or more pendant reactive functional groups. The second scaffold capable of reacting with the one or more pendant reactive functional groups of the first scaffold.Type: GrantFiled: May 12, 2010Date of Patent: April 15, 2014Assignee: Covidien LPInventors: Arpan Desai, Timothy Sargeant, Atu Agawu, Joshua Stopek
-
Patent number: 8691543Abstract: The invention is directed to a device and method to prevent migration of Human Mesenchymal Stem Cells (hMSCs) from a delivery site while allowing communication between the stem cells and native cardiomyocytes. The device is characterized by scaffold pore size, fiber diameter and biomaterial selection. The invention includes a two part polyurethane scaffold that prevents migration of stem cells, allows gap junction formation through pores and is packaged for minimally invasive delivery.Type: GrantFiled: November 26, 2010Date of Patent: April 8, 2014Assignee: Worcester Polytechnic InstituteInventors: Glenn Gaudette, Matthew D. Phaneuf, Syed Ali, Brian Almeida, Helena Alfonzo, Katie Flynn
-
Patent number: 8691203Abstract: The present inventions in various aspects provide elastic biodegradable polymers. In various embodiments, the polymers are formed by the reaction of a multifunctional alcohol or ether and a difunctional or higher order acid to form a pre-polymer, which is cross-linked to form the elastic biodegradable polymer. In preferred embodiments, the cross-linking is performed by functionalization of one or more OR groups on the pre-polymer backbone with vinyl, followed by photopolymerization to form the elastic biodegradable polymer composition or material. Preferably, acrylate is used to add one or more vinyls to the backbone of the pre-polymer to form an acrylated pre-polymer. In various embodiments, acrylated pre-polymers are co-polymerized with one or more acrylated co-polymers.Type: GrantFiled: March 23, 2012Date of Patent: April 8, 2014Assignee: Massachusetts Institute of TechnologyInventors: Christopher J. Bettinger, Joost P. Bruggeman, Lino Da Silva Ferreira, Jeffrey M. Karp, Robert S. Langer, Christiaan Nijst, Andreas Zumbuehl, Jason Burdick, Sonia J. Kim
-
Patent number: 8679825Abstract: Protein-polymer composite materials are provided according to embodiments of the present invention that include an admixture of a polymer resin, a surfactant and a non-aqueous organic solvent. An aqueous solution containing bioactive proteins is mixed with the admixture. The emulsion is mixed with a crosslinker to produce a curable composition. The curable composition is cured, thereby producing the protein-polymer composite material that is useful for facilitating removal of bioorganic stains.Type: GrantFiled: September 27, 2010Date of Patent: March 25, 2014Assignees: Toyota Motor Engineering & Manufacturing North America, Inc., Regents of the University of Minnesota, Toyota Motor CorporationInventors: Ping Wang, Songtao Wu, Hongfei Jia, Masahiko Ishii, Xiaodong Tong, Minjuan Zhang
-
Patent number: 8679808Abstract: The present invention discloses a method for fabricating aerogels, a method for fabricating surface-modified aerogels, and a method for fabricating biocomposites. Take the fabricating method of biocomposites for example, first, a precursor solution is provided and the precursor solution comprises a hydrophilic ionic liquid, a catalyzed hydrolysis and/or condensation reagent, at least one biomolecule. Next, a curing process is performed for the precursor solution to hydrolyze and polymerize the at least one alkoxide monomer and/or aryloxide monomer to wrap at least one biomolecule and thus form biocomposite. Afterwards, an extracting process is performed by a solvent for the biocomposite to substitute the ionic liquid in the biocomposite. Finally, a drying process for the biocomposite is carried out after the extracting process so as to remove the solvent in the biocomposite. Therefore, the biocomposite is formed.Type: GrantFiled: November 17, 2010Date of Patent: March 25, 2014Assignee: Chung Yuan Christian UniversityInventors: Yui-Whei Chen-Yang, Yen-Kuang Li, Ching-Yao Yuan, Tzong-Yuan Wu
-
Patent number: 8673588Abstract: The present invention relates to a composition and method for handling tissue samples for analysis. In particular the present invention relates to a composition and method for orientating tissue for histological and/or pathological laboratory analysis.Type: GrantFiled: September 5, 2007Date of Patent: March 18, 2014Assignee: Leica Biosystems Melbourne Pty LtdInventors: Jason Douglas Watling, Nick Hausler, Costa Conn
-
Patent number: 8673294Abstract: An immunoisolation patch system, and particularly a patch system comprising multiple immunoisolation microcapsules, each encapsulating biological material such as cells for transplantation, which can be used in the prophylactic and therapeutic treatment of disease in large animals and humans without the need for immunosuppression.Type: GrantFiled: April 23, 2009Date of Patent: March 18, 2014Assignee: Vanderbilt UniversityInventor: Taylor G. Wang
-
Publication number: 20140051144Abstract: The present invention relates to compositions for encapsulation of biomaterials in a silica-matrix. The present invention includes a composition for formation of a silica-matrix encapsulated biomaterial. The composition includes a reactive silicon compound and a biomaterial with a catalytic activity. When encapsulated in the silica-matrix, the biomaterial at least partially retains its catalytic activity. The present invention also relates to methods of making silica-matrix encapsulated biomaterials, and to methods of using silica-matrix encapsulated biomaterials, including methods of treating water or gas using the silica-matrix encapsulated biomaterials.Type: ApplicationFiled: February 22, 2012Publication date: February 20, 2014Applicant: REGENTS OF THE UNIVERSITY OF MINNESOTAInventors: Lawrence P. Wackett, Alptekin Aksan, Michael J Sadowsky, Eduardo Reategui, Lisa Kasinkas
-
Publication number: 20140045241Abstract: The present invention generally relates to immobilized enzymes for use in carbon capture and other systems; particularly, materials used to immobilize carbonic anhydrase are disclosed.Type: ApplicationFiled: March 8, 2012Publication date: February 13, 2014Applicant: Akermin, Inc.Inventors: Tracy Bucholz, Tizah Anjeh
-
Publication number: 20140037588Abstract: Provided herein are compositions, devices and systems comprising thermoresponsive, biodegradable elastomeric materials, and methods of use and manufacture thereof.Type: ApplicationFiled: January 31, 2012Publication date: February 6, 2014Applicant: NORTHWESTERN UNIVERSITYInventors: Jian Yang, Robert Van Lith, Guillermo Ameer
-
Patent number: 8642309Abstract: The invention relates to an amphiphilic polymer comprising at least 75% of amphiphilic monomers of formula (I), the average molar mass of the polymer being between 800 and 100 000, and also water-soluble complexes between the polymer according to the invention and a hydrophobic or amphiphilic compound, in particular a membrane protein, a concentrated aqueous solution of one or more such complex(es), a product comprising one or more such complex(es) attached to a substrate by means of the polymer according to the invention, and various uses of these products.Type: GrantFiled: November 16, 2010Date of Patent: February 4, 2014Assignees: Centre National de la Recherche Scientifique (CNRS), University d'Avignon et des Pays de VaucluseInventors: Bernard Pucci, Fabrice Giusti, Paola Bazzacco, Jean-Luc Popot, Sharma Kshatrapati Shivaji, Gregory Durand
-
Patent number: 8633027Abstract: Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.Type: GrantFiled: March 24, 2011Date of Patent: January 21, 2014Assignee: Allergan, Inc.Inventors: Gregory H. Altman, Jingson Chen, Rebecca L. Horan, David J. Horan
-
Publication number: 20140017284Abstract: Macroporous 3-D tissue engineering scaffold comprising elastomeric cross-linked polymer units and interconnected macropores containing living cells are produced by step of: in a mixture of the cells and elastomeric polymer units comprising activatable crosslinking groups, activating the crosslinking groups to form the scaffold.Type: ApplicationFiled: July 16, 2013Publication date: January 16, 2014Inventors: Fan Yang, Li-Hsin Han, Xinming Tong
-
Publication number: 20130344130Abstract: A smart antimicrobial material and dressing to inhibit microbial growth is provided. Endogenous chemicals, such as metabolites produced from bacteria are utilized as chemical substrates and converted by enzymes to produce a disinfecting compound that will in turn inhibit the targeted microorganism. The material shall remain passive until such time as it encounters a microbe which expresses and/or secretes specific metabolites or markers. The enzyme or enzymes embedded in the smart material converts the metabolite into a disinfecting compound, which in turn either kills the microorganism or prevents it from multiplying on the surface of the material.Type: ApplicationFiled: June 12, 2013Publication date: December 26, 2013Inventors: Anna M. Leech, Jeremy P. Walker, Scott Donahue, Jermaine D. Johnson, Jessica J. Sinclair
-
Publication number: 20130345655Abstract: A sanitary article is provided that includes a dried polymeric matrix with embedded enzyme. The presence of the enzyme in the polymeric matrix allows the sanitary article to absorb a bodily discharge fluid thereby allowing the embedded enzyme to function in the production of antibacterial compounds or by directly reducing the presence of viable bacteria in the discharge fluid. The enzyme activity promotes reduced odor in the sanitary article.Type: ApplicationFiled: June 21, 2012Publication date: December 26, 2013Applicants: Toyota Motor Corporation, Toyota Motor Engineering & Manufacturing North America, Inc.Inventors: Songtao Wu, Hongfei Jia, Masahiko Ishii, Minjuan Zhang
-
Patent number: 8584892Abstract: A packet of an enzyme and/or enzyme producing bacteria is contained within the core of a roll of toilet tissue or similar paper product wound on a core. The packet has a cover that dissolves or disintegrates on contact with water and disperses its contents into the aqueous waste stream. The packet may contain a mixture of bacterial cultures that produce enzymes to attack the greasy or fatty components of the waste stream. An additional article such as a sample of a liquid or creme personal care product may also be contained within the tissue paper core.Type: GrantFiled: January 19, 2010Date of Patent: November 19, 2013Inventor: Joseph R. Lira
-
Patent number: 8574880Abstract: This invention relates to a method of immobilizing biocatalysts including protein and cells by co-precipitation with silicate or organosilicate matrices through the action of an organic template molecule. The organic template molecule is in general a polyamine such as polyethylenimine (PEI), or polypeptide compound bearing at least two or three basic residues selected from the group consisting of lysine, arginine, histidine, proline, hydroxyproline, N-methylhistidine, ornithine, taurine, ?-hydroxylysine, and ?-hydroxy-?-N,N,N trimethyllysine. The invention is also directed to a silica biocomposite comprising co-precipitates of active biocatalysts, silica or organosilicates, and an N-containing organic template molecule. Such silica biocomposites are useful in biocatalysis, and other applications requiring an immobilized biocatalyst. Preferred biocatalysts for this invention are enzymes and whole cells.Type: GrantFiled: February 27, 2009Date of Patent: November 5, 2013Assignee: Danisco US, Inc.Inventors: Risha Bond, Michael C. Jewett, Joseph C. McAuliffe, Donald E. Ward, II
-
Publication number: 20130288330Abstract: Provided are: a capsule for non-ferrous metal collection that can collect a non-ferrous metal; and a method for collecting a non-ferrous metal using same. The capsule for non-ferrous metal collection comprises capsule contents and a covering section covering the capsule contents, and collects a non-ferrous metal within the capsule for non-ferrous metal collection by means of the capsule for non-ferrous metal collection being immersed in a solution containing a non-ferrous metal.Type: ApplicationFiled: November 2, 2011Publication date: October 31, 2013Applicants: MORISHITA JINTAN CO., LTD.Inventors: Yasuhiro Konishi, Koshiro Tamaoki, Ryosei Kamaguchi, Daisuke Tagawa, Taku Hashimoto, Masaaki Nakatsuji
-
Publication number: 20130267004Abstract: The present invention generally relates to improvements in enzyme immobilization, particularly for use in the field of carbon dioxide capture and sequestering. It has been discovered that the utilization of sol-gel processes to immobilize enzymes in polysilicate-polysilicone copolymer coatings and particles, and the deposition of these coatings on solid state supports or use of suspensions of these particles, provides significant benefits for use in industrial applications involving enzymatic catalysts.Type: ApplicationFiled: March 15, 2013Publication date: October 10, 2013Applicant: AKERMIN, INC.Inventors: Brett M. Rambo, Tracy L. Bucholz, Dawn C. Powell, Luke E. Weber, Alexander J. Linder, Caroline M.H. Duesing, Aleksey Zaks
-
Patent number: 8545927Abstract: The invention provides biomatrix compositions comprising cross-linked lactoferrin, either alone or in combination with other organic or inorganic components. Also provided are methods of making and using the biomatrix compositions. As described herein, cross-linked lactoferrin biomatrix retains the bioactivities of the lactoferrin molecule. The biomatrix composition can act as a matrix for cell adhesion and growth and is particularly useful in musculoskeletal tissue regeneration. The biomatrix compositions can be pre-formed or injectable and can act as a cell, drug or protein delivery vehicle.Type: GrantFiled: May 10, 2011Date of Patent: October 1, 2013Assignee: University of ConnecticutInventor: Lakshmi Sreedharan Nair
-
Publication number: 20130244301Abstract: The present invention provides a thermoresponsive nanoparticle useful for the stabilization of enzymes in environments having a temperature greater than thirty degrees Centigrade. The thermoresponsive nanoparticle has (a) a functionalized enzyme conjugate having one or more enzymes or biological catalysts, the enzymes or biological catalysts are modified with palmitic acid N-hydroxysuccinimide ester and acryclic acid N-hydroxysuccinimide ester, and (b) a thermally responsive polymer, wherein the functionalized enzyme conjugate is encapsulated within the thermally responsive polymer. A nanocatalyst is provided that has one or more proteins. The proteins are covalently immobilized and encapsulated within a thermally responsive polymer shell. The proteins are one or more enzymes or biological catalysts. A method for protecting the proteins is also set forth.Type: ApplicationFiled: May 7, 2013Publication date: September 19, 2013Inventors: Jeremy P. Walker, Anna M. Leech
-
Patent number: 8535924Abstract: A granule with an allergenic component has reduced dust by including antifoam added during the production of the granule. The antifoam may be dispersed throughout the granule or added to one of the components of the granule. The granule with antifoam produces at least 30% less dust than a comparable granule produced according to a process in which no antifoam is added.Type: GrantFiled: November 3, 2011Date of Patent: September 17, 2013Assignee: Danisco US Inc.Inventors: Douglas A. Dale, Thomas S. Green
-
Publication number: 20130224826Abstract: A bioactive composition includes a porous hydrogel matrix. At least one protein is immobilized in the porous hydrogel matrix forming a hydrogel protein composite that is stable in an organic solvent. A process for stabilizing a bioactive composition includes the steps of: forming hydrogel matrix pores around protein molecules and reducing water content within the hydrogel matrix pores forming a hydrogel protein composite that is stable in an organic solvent.Type: ApplicationFiled: April 3, 2013Publication date: August 29, 2013Applicants: Toyota Motor Engineering & Manufacturing North America, Inc., Toyota Motor Corporation, Regents of the University of MinnesotaInventors: Toyota Motor Engineering & Manufacturing North America, Inc., Regents of the University of Minnesota, Toyota Motor Corporation
-
Publication number: 20130224799Abstract: A method is disclosed for improved isothermal amplification of nucleic acids comprising the step of release of an essential component from a matrix under predetermined conditions. Furthermore, the invention relates to a kit comprising mesophilic enzyme and a matrix with embedded essential components for isothermal amplification. A composition comprising a matrix and a mesophilic enzyme and a method for embedding a mesophilic enzyme are disclosed as well.Type: ApplicationFiled: August 9, 2011Publication date: August 29, 2013Applicant: QIAGEN GMBHInventor: Christian Korfhage
-
Patent number: 8518682Abstract: A tissue engineering composition adapted for application to an interior surface of a body lumen of a patient. The composition comprises (a) a carrier medium that is adapted to flow and to stably adhere the composition to the body lumen and (b) microcapsules, which are dispersed within the carrier medium and which contain one or more living cells encapsulated within a coating that includes a biodegradable polymer. The composition promotes growth of the cells on the lumen surface subsequent to application of the composition to the lumen.Type: GrantFiled: December 13, 2010Date of Patent: August 27, 2013Assignee: Boston Scientific Scimed, Inc.Inventors: Toby M. Freyman, Joseph A. Levendusky
-
Publication number: 20130196405Abstract: There is provided a porous fiber having a core-shell configuration, wherein the pores on the fiber are configured to encapsulate and thereby retain a biological material therein.Type: ApplicationFiled: November 11, 2011Publication date: August 1, 2013Applicant: NGEE ANN POLYTECHNICInventors: Gurdev Singh, Binoy Paulose Nadappuram, Shuchi Agarwal, Nandhini Elayaperumal
-
Publication number: 20130173018Abstract: A method for manufacturing a multilayered cell sheet characterized in fabricating a vascular bed that constructs a vascular network extending to the surface from a channel for perfusing a medium, the channel being embedded in a gel; and layering a cell sheet onto the vascular bed to construct a vascular network in the cell sheet. This manufacturing method makes it possible to construct a vascular network in the cell sheet and to fabricate a thick multilayered cell sheet in a simple manner by layering cell sheets. Such a thick multilayered cell sheet is useful as an in-vivo tissue substitute in regenerative medicine involving a variety of tissues.Type: ApplicationFiled: September 14, 2011Publication date: July 4, 2013Applicant: TOKYO WOMEN'S MEDICAL UNIVERSITYInventors: Katsuhisa Sakaguchi, Tatsuya Shimizu, Hidekazu Sekine, Mitsuo Umezu, Teruo Okano
-
Publication number: 20130157336Abstract: Disclosed are methods, compositions and kits pertaining to polymer coatings that entrap enzymes, specifically enzymes capable of degrading bisphenol A.Type: ApplicationFiled: December 19, 2011Publication date: June 20, 2013Applicant: Empire Technology Development LLCInventor: Robert M. Cabrera
-
Patent number: 8460907Abstract: The present invention provides a thermoresponsive nanoparticle useful for the stabilization of enzymes in environments having a temperature greater than thirty degrees Centigrade. The thermoresponsive nanoparticle has (a) a functionalized enzyme conjugate having one or more enzymes or biological catalysts, the enzymes or biological catalysts are modified with palmitic acid N-hydroxysuccinimide ester and acrylic acid N-hydroxysuccinimide ester, and (b) a thermally responsive polymer, wherein the functionalized enzyme conjugate is encapsulated within the thermally responsive polymer. A nanocatalyst is provided that has one or more proteins. The proteins are covalently immobilized and encapsulated within a thermally responsive polymer shell. The proteins are one or more enzymes or biological catalysts. A method for protecting the proteins is also set forth.Type: GrantFiled: November 11, 2010Date of Patent: June 11, 2013Assignee: ICx-AgentaseInventors: Jeremy P. Walker, Anna M. Leech
-
Publication number: 20130130284Abstract: Disclosed is a composite of enzyme and fiber matrix with three-dimensional structure. The composite of enzyme and fiber matrix with three-dimensional structure includes a significantly large amount of an enzyme loaded in and immobilized in/onto a matrix when compared to conventional composites. In addition, the immobilized enzyme is prevented from leaching from the matrix when an external impact is applied to the composite of enzyme and fiber matrix with three-dimensional structure. Therefore, the stability of the composite of enzyme and fiber matrix with three-dimensional structure of the present invention is maintained even after a long period passes since a remarkably great amount of enzymes compared with a known composite can be supported and immobilized to a matrix, and the immobilized enzyme is not easily released by an external impact.Type: ApplicationFiled: April 19, 2011Publication date: May 23, 2013Applicant: KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATIONInventors: Jungbae Kim, Hyeong-Seok Kim
-
Publication number: 20130130910Abstract: [Problem] Provision of sustained release microparticles having excellent characteristics, in which the microparticles for supporting a substance or substances can fully control the release of the supported substances, can sufficiently diffuse the supported substances in a medium such as water, and can effect sustained release of more than one kind of the supported substances differing in water solubility, each at the respectively desired rate; and also to provide preparations which contain said sustained release microparticles. [Means of Solution] Sustained release microparticles comprising a supported substance, microgranular form and coating agent, said microgranular form having an average particle size within a range of from 20 to 300 ?m; and preparations which contain the sustained release microparticles.Type: ApplicationFiled: July 15, 2011Publication date: May 23, 2013Inventors: Youichi Hori, Satoru Ishimori, Mitsuyoshi Sato
-
Publication number: 20130115673Abstract: Aspects of the present invention include methods and compositions related to the production and use of numerous clonal lineages of embryonic progenitor cell lines derived from differentiating cultures of primordial stem cells with diverse molecular markers and having been cultured for >21 doublings of clonal expansion. The robustness of these clonally-purified lines, their ability to expand for >40 passages while maintaining their pattern of gene expression, lack of tumorigenicity, and their embryonic pattern of gene expression offers novel compositions and methods for modeling numerous differentiation pathways for the first time in vitro, and for the manufacture of purified product not existing in such a purified state in nature or using other manufacturing modalities. Representative progenitor cell lines described herein are capable of development into cutaneous adipocytes, blood-brain barrier cells, neuronal cells, or smooth muscle cells each with therapeutic potential.Type: ApplicationFiled: November 21, 2012Publication date: May 9, 2013Applicant: BIOTIME, INC.Inventor: BioTime, Inc.
-
Patent number: 8426192Abstract: An electrochemical sensor system and membrane and method thereof for increased accuracy and effective life of electrochemical and enzyme sensors.Type: GrantFiled: December 14, 2009Date of Patent: April 23, 2013Assignee: Instrumentation Laboratory CompanyInventors: Prasad Pamidi, Sohrab Mansouri, Melanie Shin, Vasile Cosofret, Clarke Xu
-
Patent number: 8420891Abstract: Disclosed is a method for introducing a foreign substance (3) into a cell (1) having a cell wall. The method comprises the steps of: providing a carbon nanotube (2) carrying at least one enzyme capable of decomposing a cell wall; supplying the carbon nanotube (2) and the foreign substance (3) into a treatment solution containing the cell (1); decomposing the cell wall of the cell (1) by the action of the enzyme carried on the carbon nanotube (2) upon the contact of the carbon nanotube (2) with the cell (1); and introducing the foreign substance (3) into the cell (1) through a site decomposed with the enzyme on the cell wall.Type: GrantFiled: June 11, 2008Date of Patent: April 16, 2013Assignee: National University Corporation Nagoya UniversityInventors: Yoshinobu Baba, Manabu Tokeshi, Noritada Kaji, Ibrahim Maged Fouad Serag Eldin Bayoumi
-
Patent number: 8415173Abstract: A gel microdrop composition is provided. In certain embodiments, the gel microdrop composition contains a polymer matrix, an effector particle that releases an effector molecule into the polymer matrix, a first reporter particle that emits a first optically detectable signal and a second reporter particle that emits a second optically detectable signal that is distinguishable from the first optically detectable signal, where the effector particle and said first and second reporter particles are encapsulated by the polymer matrix. Methods of screening that employ the gel microdrop composition and methods of making the gel microdrop composition are also disclosed.Type: GrantFiled: August 26, 2011Date of Patent: April 9, 2013Assignee: Crystal Bioscience Inc.Inventor: William Don Harriman
-
Patent number: 8399230Abstract: The thermal stability of enzymes is improved by incorporating the enzyme in a matrix of a non-reducing sugar, such as trehalose. Heat-stable compositions of enzymes and sugar are formed by adding the enzymes to a sugar syrup and drying the mixture either by spreading it on a carrier or by spray drying. The enzyme compositions retain higher levels of activity after being subjected to heat in product-forming processes, such as steam pelleting of animal feed supplemented with the enzyme compositions.Type: GrantFiled: October 12, 2006Date of Patent: March 19, 2013Assignee: Kemin Industries, Inc.Inventors: Stefaan M. O. Van Dyck, Bruno Coppens, Ingrid Somers, Clifford A. Adams
-
Patent number: 8383361Abstract: A polymer matrix that may coated on an electrode is created by co-crosslinking (1) an adduct of a polyaniline formed by templated oxidative polymerization on a polymer acid; (2) a water-soluble crosslinker; and (3) a redox enzyme. The polymer matrix may be hydrated, and the absorbed water may make it permeable to, for example, glucose. The polyaniline may be polyaniline itself or a substituted polyaniline; the water-soluble crosslinker may be poly(ethylene glycol)diglycidyl ether, and the redox enzyme may be glucose oxidase. The polymer matrix may be produced by co-crosslinking (1) an adduct of an electrically conductive polymer and a polymer acid; (2) a water-soluble crosslinker; and (3) a redox enzyme in a single step at an about neutral pH, curing by drying. After hydration, the crosslinked polymer matrix may form a 3-dimensional glucose-permeable bioelectrocatalyst, catalyzing the electrooxidation of glucose.Type: GrantFiled: December 14, 2011Date of Patent: February 26, 2013Assignee: Abbott Diabetes Care Inc.Inventors: Adam Heller, Benjamin J. Feldman, Nicolas Mano, Yueh-Lin Loo
-
Publication number: 20130040357Abstract: The present invention relates to a hydrogel precursor formulation, its process of production as well as a kit comprising said formulation and a method of production of a hydrogel using said formulation. The precursor formulation comprises at least one structural compound, preferably vinyl sulfone (acrylated branched) poly(ethylene glycol), and at least one linker compound, preferably a peptide with two cysteines, wherein said structural compound and said linker compound are polymerizable by a selective reaction between a nucleophile and a conjugated unsaturated bond or group. The precursor formulation is in the form of a powder.Type: ApplicationFiled: April 19, 2011Publication date: February 14, 2013Applicant: QGEL SAInventors: Simone Rizzi, Matthias Lutolf